OBJECTIVES Health care workers, including dentists, are at the front line for acquiring blood-borne virus infections. This study aimed to investigate the prevalence of hepatitis B, hepatitis C and human immunodeficiency viruses among Iranian dentists. MATERIAL AND METHODS The survey included 1628 dental health care workers who attended the 51st annual Congress of the Iranian Dental Associatio...

BACKGROUND AND AIM Antibodies against hepatitis B core antigen (anti-HBc) are found in 14-44% of patients with HIV infection, but it is still unclear whether hepatitis B virus (HBV) vaccination should be recommended for HIV-positive subjects with isolated anti-HBc (IAHBc). We examined the rate of anamnestic and primary responses (ARs and PRs) and associated factors in a group of HIV-infected pa...

BACKGROUND Diseases caused by Hepatitis B virus (HBV) have a worldwide distribution. Pakistan adopted the recommendations of World Health Organization (WHO) for routine universal infant vaccination against hepatitis B in 2002, currently being administered at 6, 10, and 14 weeks of age in a combination vaccine. This study was conducted to determine the immune response & anamnestic immune respons...

results the results of this study indicated that the overall hepatitis b vaccine acceptance rate was acceptably high. among all, 53.5% correctly identified that a vaccine to prevent hepatitis b virus infection had been available, 15% had a negative opinion, and 31.5% were neutral. the rations of all three doses of vaccination were 69.3%. conclusions among the respondents, 87% were currently mar...

abstract background: naturally occurred hepatitis b virus (hbv) with surface mutations in a variety of chronic hepatitis b (chb) patients who have received no vaccine or hbig bearing substitutions in surface protein, have been reported. objectives: current knowledge concerning the prevalence of these naturally occurring surface antigen mutations among iranian carriers is limited. patients and m...

BACKGROUND Immunotherapy of patients suffering from the human epidermal growth factor receptor 2 overexpressing (HER-2(+)) breast cancers with the anti-HER-2 antibodies results in increase of the patients' overall survival. However, no prophylactic vaccine is available against HER-2(+) breast cancers. Although, prophylactic vaccine for human hepatitis B virus (HBV) is very effective. SPECIFIC...

BACKGROUND Hepatitis B virus (HBV) infection is endemic in China; perinatal transmission is the main source of chronic HBV infection. Simultaneous administration of hepatitis B immune globulin (HBIG) and hepatitis B vaccine is highly effective to prevent perinatal transmission of HBV; however, the effectiveness also depends on full adherence to the recommended protocols in daily practice. In th...

To the Editor—It was with interest that we read the study by Frey et al. [1], which describes a randomized trial in which 3 manufacturing consistency lots of a combined hepatitis A and B vaccine were compared with the corresponding monovalent vaccines. The authors observed a nonsatisfactory response to the hepatitis B component in the combined vaccine. We are concerned that this report may be m...

Objectives: To assess the immunogenicity of Hepatitis B Vaccine in children with thalassemia.
 Study Design: Prospective longitudinal study.
 Place and Duration Study: Pak Emirates Military Hospital, Rawalpindi Pakistan from Aug 2018 to Jan 2019.
 Methodology: After ethical approval informed consent, 150 diagnosed patients thalassemia were selected Thalassemia centre at Hospital ...